| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.79▲ | 3.79▲ | 3.79▲ | 3.77▲ | 3.92▼ |
| MA10 | 3.78▲ | 3.79▲ | 3.78▲ | 3.87▼ | 3.94▼ |
| MA20 | 3.78▲ | 3.78▲ | 3.74▲ | 4.09▼ | 3.85▼ |
| MA50 | 3.79▲ | 3.73▲ | 3.84▼ | 4.02▼ | 3.42▲ |
| MA100 | 3.78▲ | 3.86▼ | 3.96▼ | 3.93▼ | 3.00▲ |
| MA200 | 3.74▲ | 4.01▼ | 4.12▼ | 3.67▲ | 3.28▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.001▲ | 0.017▲ | -0.053▼ | -0.044▼ |
| RSI | 56.005▲ | 55.930▲ | 53.546▲ | 43.863▼ | 50.955▲ |
| STOCH | 44.841 | 66.948 | 76.929 | 24.988 | 41.367 |
| WILL %R | -14.286▲ | -16.667▲ | -14.815▲ | -76.000▼ | -68.208 |
| CCI | 166.250▲ | 37.168 | 79.085 | -89.862 | -43.603 |
|
Wednesday, April 01, 2026 01:55 PM
The Grant was offered as material inducement to the employee's employment. The Grant was approved by the Compensation Committee of the Company's Board of Directors pursuant to the ...
|
|
Thursday, March 26, 2026 06:29 PM
ADC Therapeutics (NYSE:ADCT) executives used a recent fireside chat at the H.C. Wainwright conference to outline the company’s strategy to expand the reach of its CD19-directed antibody-drug conjugate ...
|
|
Wednesday, March 18, 2026 11:46 PM
Detailed price information for Adc Therapeutics Sa (ADCT-N) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/04/26 | 3.81 | 3.83 | 3.70 | 3.80 | 744,557 |
| 31/03/26 | 3.725 | 3.81 | 3.63 | 3.75 | 919,129 |
| 30/03/26 | 3.69 | 3.78 | 3.56 | 3.64 | 678,180 |
| 27/03/26 | 3.89 | 4.00 | 3.605 | 3.70 | 999,836 |
| 26/03/26 | 3.89 | 4.05 | 3.89 | 3.96 | 485,894 |
| 25/03/26 | 3.99 | 4.11 | 3.94 | 3.97 | 523,463 |
| 24/03/26 | 3.97 | 4.00 | 3.87 | 3.94 | 354,274 |
| 23/03/26 | 4.10 | 4.12 | 3.94 | 4.05 | 662,335 |
| 20/03/26 | 4.12 | 4.12 | 3.84 | 3.86 | 2,218,880 |
| 19/03/26 | 3.94 | 4.09 | 3.92 | 4.04 | 428,022 |
|
|
||||
|
|
||||
|
|